nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS1—esophageal cancer	0.415	0.636	CbGaD
Mefenamic acid—PTGS2—esophageal cancer	0.237	0.364	CbGaD
Mefenamic acid—PTGS2—Cisplatin—esophageal cancer	0.0638	0.496	CbGbCtD
Mefenamic acid—CYP2C9—Capecitabine—esophageal cancer	0.043	0.335	CbGbCtD
Mefenamic acid—CYP2C9—Cisplatin—esophageal cancer	0.0217	0.169	CbGbCtD
Mefenamic acid—Glucose tolerance impaired—Cisplatin—esophageal cancer	0.00315	0.0356	CcSEcCtD
Mefenamic acid—Gastrointestinal perforation—Capecitabine—esophageal cancer	0.00239	0.0271	CcSEcCtD
Mefenamic acid—Meningitis aseptic—Methotrexate—esophageal cancer	0.00197	0.0224	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—HSPA5—esophageal cancer	0.0017	0.188	CrCbGaD
Mefenamic acid—Infection—Carboplatin—esophageal cancer	0.00102	0.0116	CcSEcCtD
Mefenamic acid—Bone marrow depression—Capecitabine—esophageal cancer	0.000925	0.0105	CcSEcCtD
Mefenamic acid—Haematemesis—Capecitabine—esophageal cancer	0.000899	0.0102	CcSEcCtD
Mefenamic acid—Ulcer—Cisplatin—esophageal cancer	0.000896	0.0101	CcSEcCtD
Mefenamic acid—Hearing impaired—Cisplatin—esophageal cancer	0.00089	0.0101	CcSEcCtD
Mefenamic acid—Body temperature increased—Carboplatin—esophageal cancer	0.000815	0.00923	CcSEcCtD
Mefenamic acid—Fluid retention—Cisplatin—esophageal cancer	0.000804	0.00911	CcSEcCtD
Mefenamic acid—Eye irritation—Capecitabine—esophageal cancer	0.000731	0.00828	CcSEcCtD
Mefenamic acid—Proteinuria—Capecitabine—esophageal cancer	0.000711	0.00805	CcSEcCtD
Mefenamic acid—Protein urine present—Capecitabine—esophageal cancer	0.000701	0.00794	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—TP53—esophageal cancer	0.000701	0.0775	CrCbGaD
Mefenamic acid—Polyuria—Cisplatin—esophageal cancer	0.0007	0.00793	CcSEcCtD
Mefenamic acid—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000691	0.00783	CcSEcCtD
Mefenamic acid—Bone marrow depression—Methotrexate—esophageal cancer	0.000689	0.0078	CcSEcCtD
Mefenamic acid—Deafness—Cisplatin—esophageal cancer	0.000687	0.00779	CcSEcCtD
Mefenamic acid—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000681	0.00772	CcSEcCtD
Mefenamic acid—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000678	0.00768	CcSEcCtD
Mefenamic acid—Haematemesis—Methotrexate—esophageal cancer	0.000669	0.00758	CcSEcCtD
Mefenamic acid—Ulcer—Capecitabine—esophageal cancer	0.00066	0.00748	CcSEcCtD
Mefenamic acid—Hearing impaired—Capecitabine—esophageal cancer	0.000656	0.00743	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000635	0.0072	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS1—esophageal cancer	0.00063	0.0697	CrCbGaD
Mefenamic acid—Hyponatraemia—Cisplatin—esophageal cancer	0.000617	0.00699	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000615	0.00697	CcSEcCtD
Mefenamic acid—Melaena—Capecitabine—esophageal cancer	0.00061	0.00691	CcSEcCtD
Mefenamic acid—Colitis—Capecitabine—esophageal cancer	0.0006	0.00679	CcSEcCtD
Mefenamic acid—Fluid retention—Capecitabine—esophageal cancer	0.000593	0.00672	CcSEcCtD
Mefenamic acid—Oesophagitis—Capecitabine—esophageal cancer	0.000571	0.00646	CcSEcCtD
Mefenamic acid—Ecchymosis—Capecitabine—esophageal cancer	0.000565	0.0064	CcSEcCtD
Mefenamic acid—Urine output increased—Capecitabine—esophageal cancer	0.000565	0.0064	CcSEcCtD
Mefenamic acid—Sepsis—Capecitabine—esophageal cancer	0.000542	0.00614	CcSEcCtD
Mefenamic acid—Ear pain—Capecitabine—esophageal cancer	0.000531	0.00602	CcSEcCtD
Mefenamic acid—Proteinuria—Methotrexate—esophageal cancer	0.000529	0.00599	CcSEcCtD
Mefenamic acid—Protein urine present—Methotrexate—esophageal cancer	0.000522	0.00591	CcSEcCtD
Mefenamic acid—Pancreatitis—Cisplatin—esophageal cancer	0.000521	0.0059	CcSEcCtD
Mefenamic acid—Polyuria—Capecitabine—esophageal cancer	0.000516	0.00585	CcSEcCtD
Mefenamic acid—Photosensitivity—Capecitabine—esophageal cancer	0.000516	0.00585	CcSEcCtD
Mefenamic acid—Vascular purpura—Capecitabine—esophageal cancer	0.000507	0.00574	CcSEcCtD
Mefenamic acid—Deafness—Capecitabine—esophageal cancer	0.000507	0.00574	CcSEcCtD
Mefenamic acid—Pancytopenia—Cisplatin—esophageal cancer	0.000505	0.00572	CcSEcCtD
Mefenamic acid—Oliguria—Methotrexate—esophageal cancer	0.000504	0.00571	CcSEcCtD
Mefenamic acid—Glossitis—Methotrexate—esophageal cancer	0.000504	0.00571	CcSEcCtD
Mefenamic acid—Hepatic failure—Capecitabine—esophageal cancer	0.000504	0.00571	CcSEcCtD
Mefenamic acid—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000502	0.00569	CcSEcCtD
Mefenamic acid—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000491	0.00557	CcSEcCtD
Mefenamic acid—Ulcer—Methotrexate—esophageal cancer	0.000491	0.00557	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00048	0.00544	CcSEcCtD
Mefenamic acid—Renal impairment—Capecitabine—esophageal cancer	0.000476	0.0054	CcSEcCtD
Mefenamic acid—Vasculitis—Methotrexate—esophageal cancer	0.000476	0.0054	CcSEcCtD
Mefenamic acid—Purpura—Capecitabine—esophageal cancer	0.00047	0.00533	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000467	0.00529	CcSEcCtD
Mefenamic acid—Renal failure—Cisplatin—esophageal cancer	0.000466	0.00528	CcSEcCtD
Mefenamic acid—Myocardial infarction—Cisplatin—esophageal cancer	0.000465	0.00526	CcSEcCtD
Mefenamic acid—Stomatitis—Cisplatin—esophageal cancer	0.000462	0.00523	CcSEcCtD
Mefenamic acid—Conjunctivitis—Cisplatin—esophageal cancer	0.000461	0.00522	CcSEcCtD
Mefenamic acid—Hyponatraemia—Capecitabine—esophageal cancer	0.000455	0.00516	CcSEcCtD
Mefenamic acid—Melaena—Methotrexate—esophageal cancer	0.000454	0.00514	CcSEcCtD
Mefenamic acid—Cystitis noninfective—Methotrexate—esophageal cancer	0.000454	0.00514	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000453	0.00514	CcSEcCtD
Mefenamic acid—Cystitis—Methotrexate—esophageal cancer	0.000449	0.00509	CcSEcCtD
Mefenamic acid—Aplastic anaemia—Methotrexate—esophageal cancer	0.000436	0.00494	CcSEcCtD
Mefenamic acid—Coma—Methotrexate—esophageal cancer	0.000425	0.00481	CcSEcCtD
Mefenamic acid—Urine output increased—Methotrexate—esophageal cancer	0.00042	0.00476	CcSEcCtD
Mefenamic acid—Ecchymosis—Methotrexate—esophageal cancer	0.00042	0.00476	CcSEcCtD
Mefenamic acid—Bladder pain—Methotrexate—esophageal cancer	0.00042	0.00476	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Cisplatin—esophageal cancer	0.00042	0.00476	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Capecitabine—esophageal cancer	0.000418	0.00474	CcSEcCtD
Mefenamic acid—Urethral disorder—Cisplatin—esophageal cancer	0.000417	0.00472	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000408	0.00462	CcSEcCtD
Mefenamic acid—Tiaprofenic acid—PTGS1—esophageal cancer	0.000406	0.0449	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS1—esophageal cancer	0.000406	0.0449	CrCbGaD
Mefenamic acid—Sepsis—Methotrexate—esophageal cancer	0.000403	0.00457	CcSEcCtD
Mefenamic acid—Gastritis—Capecitabine—esophageal cancer	0.000401	0.00454	CcSEcCtD
Mefenamic acid—Tinnitus—Cisplatin—esophageal cancer	0.000397	0.00449	CcSEcCtD
Mefenamic acid—Lymphadenopathy—Methotrexate—esophageal cancer	0.000395	0.00448	CcSEcCtD
Mefenamic acid—Asthma—Capecitabine—esophageal cancer	0.000392	0.00444	CcSEcCtD
Mefenamic acid—Nepafenac—PTGS1—esophageal cancer	0.000386	0.0427	CrCbGaD
Mefenamic acid—Photosensitivity—Methotrexate—esophageal cancer	0.000384	0.00435	CcSEcCtD
Mefenamic acid—Polyuria—Methotrexate—esophageal cancer	0.000384	0.00435	CcSEcCtD
Mefenamic acid—Arrhythmia—Cisplatin—esophageal cancer	0.00038	0.00431	CcSEcCtD
Mefenamic acid—AKR1C2—lymph node—esophageal cancer	0.000378	0.152	CbGeAlD
Mefenamic acid—Alopecia—Cisplatin—esophageal cancer	0.000376	0.00426	CcSEcCtD
Mefenamic acid—Hepatic failure—Methotrexate—esophageal cancer	0.000375	0.00425	CcSEcCtD
Mefenamic acid—Pancytopenia—Capecitabine—esophageal cancer	0.000372	0.00422	CcSEcCtD
Mefenamic acid—Dysuria—Capecitabine—esophageal cancer	0.000366	0.00415	CcSEcCtD
Mefenamic acid—Flatulence—Cisplatin—esophageal cancer	0.000365	0.00413	CcSEcCtD
Mefenamic acid—Niflumic Acid—PTGS1—esophageal cancer	0.000362	0.04	CrCbGaD
Mefenamic acid—Floctafenine—PTGS2—esophageal cancer	0.00036	0.0398	CrCbGaD
Mefenamic acid—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000358	0.00405	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000358	0.00405	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Capecitabine—esophageal cancer	0.000353	0.004	CcSEcCtD
Mefenamic acid—Pneumonia—Capecitabine—esophageal cancer	0.000351	0.00398	CcSEcCtD
Mefenamic acid—Vision blurred—Cisplatin—esophageal cancer	0.000349	0.00395	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000349	0.00395	CcSEcCtD
Mefenamic acid—Tremor—Cisplatin—esophageal cancer	0.000347	0.00393	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000346	0.00392	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000344	0.0039	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Cisplatin—esophageal cancer	0.000344	0.00389	CcSEcCtD
Mefenamic acid—Renal failure—Capecitabine—esophageal cancer	0.000343	0.00389	CcSEcCtD
Mefenamic acid—Myocardial infarction—Capecitabine—esophageal cancer	0.000342	0.00388	CcSEcCtD
Mefenamic acid—Anaemia—Cisplatin—esophageal cancer	0.000342	0.00388	CcSEcCtD
Mefenamic acid—Stomatitis—Capecitabine—esophageal cancer	0.00034	0.00386	CcSEcCtD
Mefenamic acid—Jaundice—Capecitabine—esophageal cancer	0.00034	0.00386	CcSEcCtD
Mefenamic acid—Conjunctivitis—Capecitabine—esophageal cancer	0.00034	0.00385	CcSEcCtD
Mefenamic acid—Malaise—Cisplatin—esophageal cancer	0.000334	0.00378	CcSEcCtD
Mefenamic acid—Haematuria—Capecitabine—esophageal cancer	0.000333	0.00377	CcSEcCtD
Mefenamic acid—Leukopenia—Cisplatin—esophageal cancer	0.000331	0.00376	CcSEcCtD
Mefenamic acid—Agranulocytosis—Capecitabine—esophageal cancer	0.000326	0.00369	CcSEcCtD
Mefenamic acid—Salsalate—PTGS1—esophageal cancer	0.000321	0.0355	CrCbGaD
Mefenamic acid—Convulsion—Cisplatin—esophageal cancer	0.000321	0.00364	CcSEcCtD
Mefenamic acid—Meclofenamic acid—PTGS1—esophageal cancer	0.000316	0.035	CrCbGaD
Mefenamic acid—Haemoglobin—Capecitabine—esophageal cancer	0.000315	0.00357	CcSEcCtD
Mefenamic acid—Anxiety—Cisplatin—esophageal cancer	0.000314	0.00356	CcSEcCtD
Mefenamic acid—Haemorrhage—Capecitabine—esophageal cancer	0.000314	0.00355	CcSEcCtD
Mefenamic acid—Hepatitis—Capecitabine—esophageal cancer	0.000314	0.00355	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000313	0.00355	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Methotrexate—esophageal cancer	0.000312	0.00353	CcSEcCtD
Mefenamic acid—Discomfort—Cisplatin—esophageal cancer	0.000311	0.00353	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Capecitabine—esophageal cancer	0.00031	0.00351	CcSEcCtD
Mefenamic acid—Urethral disorder—Capecitabine—esophageal cancer	0.000307	0.00348	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000304	0.00344	CcSEcCtD
Mefenamic acid—Oedema—Cisplatin—esophageal cancer	0.000302	0.00342	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Cisplatin—esophageal cancer	0.000302	0.00342	CcSEcCtD
Mefenamic acid—Infection—Cisplatin—esophageal cancer	0.0003	0.0034	CcSEcCtD
Mefenamic acid—Erythema multiforme—Capecitabine—esophageal cancer	0.000296	0.00336	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Cisplatin—esophageal cancer	0.000296	0.00335	CcSEcCtD
Mefenamic acid—Tachycardia—Cisplatin—esophageal cancer	0.000295	0.00334	CcSEcCtD
Mefenamic acid—Skin disorder—Cisplatin—esophageal cancer	0.000294	0.00333	CcSEcCtD
Mefenamic acid—Tinnitus—Capecitabine—esophageal cancer	0.000292	0.00331	CcSEcCtD
Mefenamic acid—Asthma—Methotrexate—esophageal cancer	0.000292	0.0033	CcSEcCtD
Mefenamic acid—Eosinophilia—Methotrexate—esophageal cancer	0.000289	0.00327	CcSEcCtD
Mefenamic acid—Anorexia—Cisplatin—esophageal cancer	0.000288	0.00326	CcSEcCtD
Mefenamic acid—Pancreatitis—Methotrexate—esophageal cancer	0.000286	0.00324	CcSEcCtD
Mefenamic acid—Hypotension—Cisplatin—esophageal cancer	0.000282	0.0032	CcSEcCtD
Mefenamic acid—Arrhythmia—Capecitabine—esophageal cancer	0.00028	0.00317	CcSEcCtD
Mefenamic acid—Alopecia—Capecitabine—esophageal cancer	0.000277	0.00314	CcSEcCtD
Mefenamic acid—Pancytopenia—Methotrexate—esophageal cancer	0.000277	0.00314	CcSEcCtD
Mefenamic acid—Mental disorder—Capecitabine—esophageal cancer	0.000275	0.00311	CcSEcCtD
Mefenamic acid—Dysuria—Methotrexate—esophageal cancer	0.000273	0.00309	CcSEcCtD
Mefenamic acid—Paraesthesia—Cisplatin—esophageal cancer	0.000271	0.00307	CcSEcCtD
Mefenamic acid—Dyspnoea—Cisplatin—esophageal cancer	0.000269	0.00305	CcSEcCtD
Mefenamic acid—Flatulence—Capecitabine—esophageal cancer	0.000269	0.00305	CcSEcCtD
Mefenamic acid—AKR1C3—bronchus—esophageal cancer	0.000267	0.107	CbGeAlD
Mefenamic acid—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000266	0.00302	CcSEcCtD
Mefenamic acid—Fenoprofen—PTGS1—esophageal cancer	0.000265	0.0293	CrCbGaD
Mefenamic acid—Decreased appetite—Cisplatin—esophageal cancer	0.000263	0.00298	CcSEcCtD
Mefenamic acid—Pneumonia—Methotrexate—esophageal cancer	0.000262	0.00296	CcSEcCtD
Mefenamic acid—AKR1C3—smooth muscle tissue—esophageal cancer	0.000261	0.105	CbGeAlD
Mefenamic acid—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000261	0.00296	CcSEcCtD
Mefenamic acid—Drowsiness—Methotrexate—esophageal cancer	0.00026	0.00295	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000258	0.00292	CcSEcCtD
Mefenamic acid—Vision blurred—Capecitabine—esophageal cancer	0.000257	0.00291	CcSEcCtD
Mefenamic acid—Tremor—Capecitabine—esophageal cancer	0.000256	0.0029	CcSEcCtD
Mefenamic acid—Renal failure—Methotrexate—esophageal cancer	0.000256	0.0029	CcSEcCtD
Mefenamic acid—Stomatitis—Methotrexate—esophageal cancer	0.000253	0.00287	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Capecitabine—esophageal cancer	0.000253	0.00287	CcSEcCtD
Mefenamic acid—Conjunctivitis—Methotrexate—esophageal cancer	0.000253	0.00286	CcSEcCtD
Mefenamic acid—Anaemia—Capecitabine—esophageal cancer	0.000252	0.00286	CcSEcCtD
Mefenamic acid—Feeling abnormal—Cisplatin—esophageal cancer	0.000249	0.00282	CcSEcCtD
Mefenamic acid—Haematuria—Methotrexate—esophageal cancer	0.000248	0.00281	CcSEcCtD
Mefenamic acid—Malaise—Capecitabine—esophageal cancer	0.000246	0.00279	CcSEcCtD
Mefenamic acid—Vertigo—Capecitabine—esophageal cancer	0.000245	0.00278	CcSEcCtD
Mefenamic acid—Syncope—Capecitabine—esophageal cancer	0.000245	0.00277	CcSEcCtD
Mefenamic acid—Leukopenia—Capecitabine—esophageal cancer	0.000244	0.00277	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—esophageal cancer	0.000243	0.00275	CcSEcCtD
Mefenamic acid—Palpitations—Capecitabine—esophageal cancer	0.000241	0.00273	CcSEcCtD
Mefenamic acid—Loss of consciousness—Capecitabine—esophageal cancer	0.00024	0.00272	CcSEcCtD
Mefenamic acid—AKR1C3—trachea—esophageal cancer	0.00024	0.0965	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—PTGS1—esophageal cancer	0.00024	0.0265	CrCbGaD
Mefenamic acid—Body temperature increased—Cisplatin—esophageal cancer	0.000239	0.00271	CcSEcCtD
Mefenamic acid—Hypertension—Capecitabine—esophageal cancer	0.000236	0.00267	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—esophageal cancer	0.000235	0.00266	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—esophageal cancer	0.000233	0.00264	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—esophageal cancer	0.000233	0.00264	CcSEcCtD
Mefenamic acid—Lumiracoxib—PTGS2—esophageal cancer	0.000232	0.0257	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—esophageal cancer	0.000232	0.0257	CrCbGaD
Mefenamic acid—Anxiety—Capecitabine—esophageal cancer	0.000232	0.00262	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000231	0.00261	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Methotrexate—esophageal cancer	0.000231	0.00261	CcSEcCtD
Mefenamic acid—Discomfort—Capecitabine—esophageal cancer	0.00023	0.0026	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—esophageal cancer	0.000229	0.00259	CcSEcCtD
Mefenamic acid—Dry mouth—Capecitabine—esophageal cancer	0.000227	0.00257	CcSEcCtD
Mefenamic acid—Confusional state—Capecitabine—esophageal cancer	0.000225	0.00254	CcSEcCtD
Mefenamic acid—Oedema—Capecitabine—esophageal cancer	0.000223	0.00252	CcSEcCtD
Mefenamic acid—Infection—Capecitabine—esophageal cancer	0.000221	0.00251	CcSEcCtD
Mefenamic acid—Nepafenac—PTGS2—esophageal cancer	0.000221	0.0244	CrCbGaD
Mefenamic acid—Erythema multiforme—Methotrexate—esophageal cancer	0.000221	0.0025	CcSEcCtD
Mefenamic acid—Shock—Capecitabine—esophageal cancer	0.000219	0.00248	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Capecitabine—esophageal cancer	0.000218	0.00247	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—esophageal cancer	0.000218	0.00247	CcSEcCtD
Mefenamic acid—Tachycardia—Capecitabine—esophageal cancer	0.000217	0.00246	CcSEcCtD
Mefenamic acid—Asthenia—Cisplatin—esophageal cancer	0.000217	0.00246	CcSEcCtD
Mefenamic acid—Skin disorder—Capecitabine—esophageal cancer	0.000216	0.00245	CcSEcCtD
Mefenamic acid—Anorexia—Capecitabine—esophageal cancer	0.000212	0.00241	CcSEcCtD
Mefenamic acid—Hypotension—Capecitabine—esophageal cancer	0.000208	0.00236	CcSEcCtD
Mefenamic acid—Niflumic Acid—PTGS2—esophageal cancer	0.000207	0.0229	CrCbGaD
Mefenamic acid—Diarrhoea—Cisplatin—esophageal cancer	0.000207	0.00234	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—esophageal cancer	0.000206	0.00234	CcSEcCtD
Mefenamic acid—Mental disorder—Methotrexate—esophageal cancer	0.000205	0.00232	CcSEcCtD
Mefenamic acid—Insomnia—Capecitabine—esophageal cancer	0.000202	0.00228	CcSEcCtD
Mefenamic acid—Paraesthesia—Capecitabine—esophageal cancer	0.0002	0.00227	CcSEcCtD
Mefenamic acid—Dyspnoea—Capecitabine—esophageal cancer	0.000199	0.00225	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS1—esophageal cancer	0.000197	0.0218	CrCbGaD
Mefenamic acid—Dyspepsia—Capecitabine—esophageal cancer	0.000196	0.00222	CcSEcCtD
Mefenamic acid—Decreased appetite—Capecitabine—esophageal cancer	0.000194	0.00219	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000192	0.00218	CcSEcCtD
Mefenamic acid—Vomiting—Cisplatin—esophageal cancer	0.000192	0.00218	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—esophageal cancer	0.000192	0.00217	CcSEcCtD
Mefenamic acid—Rash—Cisplatin—esophageal cancer	0.000191	0.00216	CcSEcCtD
Mefenamic acid—Constipation—Capecitabine—esophageal cancer	0.000191	0.00216	CcSEcCtD
Mefenamic acid—Dermatitis—Cisplatin—esophageal cancer	0.00019	0.00216	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—esophageal cancer	0.000189	0.00214	CcSEcCtD
Mefenamic acid—Anaemia—Methotrexate—esophageal cancer	0.000188	0.00213	CcSEcCtD
Mefenamic acid—Feeling abnormal—Capecitabine—esophageal cancer	0.000184	0.00208	CcSEcCtD
Mefenamic acid—Salsalate—PTGS2—esophageal cancer	0.000183	0.0203	CrCbGaD
Mefenamic acid—Malaise—Methotrexate—esophageal cancer	0.000183	0.00208	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—esophageal cancer	0.000183	0.00207	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000182	0.00206	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—esophageal cancer	0.000182	0.00206	CcSEcCtD
Mefenamic acid—Meclofenamic acid—PTGS2—esophageal cancer	0.000181	0.02	CrCbGaD
Mefenamic acid—Nausea—Cisplatin—esophageal cancer	0.00018	0.00203	CcSEcCtD
Mefenamic acid—Urticaria—Capecitabine—esophageal cancer	0.000177	0.00201	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS1—esophageal cancer	0.000177	0.0195	CrCbGaD
Mefenamic acid—Abdominal pain—Capecitabine—esophageal cancer	0.000176	0.002	CcSEcCtD
Mefenamic acid—Body temperature increased—Capecitabine—esophageal cancer	0.000176	0.002	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—esophageal cancer	0.000176	0.00199	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS1—esophageal cancer	0.000173	0.0191	CrCbGaD
Mefenamic acid—AKR1C3—lung—esophageal cancer	0.000172	0.0693	CbGeAlD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000172	0.00195	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—esophageal cancer	0.000171	0.00194	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—esophageal cancer	0.000167	0.00189	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—esophageal cancer	0.000166	0.00188	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—esophageal cancer	0.000165	0.00187	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—esophageal cancer	0.000162	0.00184	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—esophageal cancer	0.000161	0.00183	CcSEcCtD
Mefenamic acid—Asthenia—Capecitabine—esophageal cancer	0.00016	0.00181	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—esophageal cancer	0.000158	0.00179	CcSEcCtD
Mefenamic acid—Pruritus—Capecitabine—esophageal cancer	0.000158	0.00179	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS1—esophageal cancer	0.000157	0.0173	CrCbGaD
Mefenamic acid—Hypotension—Methotrexate—esophageal cancer	0.000155	0.00176	CcSEcCtD
Mefenamic acid—Diarrhoea—Capecitabine—esophageal cancer	0.000152	0.00173	CcSEcCtD
Mefenamic acid—Fenoprofen—PTGS2—esophageal cancer	0.000152	0.0168	CrCbGaD
Mefenamic acid—Insomnia—Methotrexate—esophageal cancer	0.00015	0.0017	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—esophageal cancer	0.000149	0.00169	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—esophageal cancer	0.000148	0.00168	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—esophageal cancer	0.000147	0.00167	CcSEcCtD
Mefenamic acid—Dizziness—Capecitabine—esophageal cancer	0.000147	0.00167	CcSEcCtD
Mefenamic acid—Dyspepsia—Methotrexate—esophageal cancer	0.000146	0.00165	CcSEcCtD
Mefenamic acid—Decreased appetite—Methotrexate—esophageal cancer	0.000144	0.00163	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000143	0.00162	CcSEcCtD
Mefenamic acid—Vomiting—Capecitabine—esophageal cancer	0.000142	0.0016	CcSEcCtD
Mefenamic acid—Rash—Capecitabine—esophageal cancer	0.00014	0.00159	CcSEcCtD
Mefenamic acid—Dermatitis—Capecitabine—esophageal cancer	0.00014	0.00159	CcSEcCtD
Mefenamic acid—Headache—Capecitabine—esophageal cancer	0.00014	0.00158	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS2—esophageal cancer	0.000137	0.0151	CrCbGaD
Mefenamic acid—Feeling abnormal—Methotrexate—esophageal cancer	0.000137	0.00155	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000136	0.00154	CcSEcCtD
Mefenamic acid—Nausea—Capecitabine—esophageal cancer	0.000132	0.0015	CcSEcCtD
Mefenamic acid—Urticaria—Methotrexate—esophageal cancer	0.000132	0.00149	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—esophageal cancer	0.000131	0.00149	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—esophageal cancer	0.000131	0.00149	CcSEcCtD
Mefenamic acid—Asthenia—Methotrexate—esophageal cancer	0.000119	0.00135	CcSEcCtD
Mefenamic acid—AKR1C3—lymph node—esophageal cancer	0.000118	0.0474	CbGeAlD
Mefenamic acid—Pruritus—Methotrexate—esophageal cancer	0.000117	0.00133	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ABCB1—esophageal cancer	0.000116	0.0129	CrCbGaD
Mefenamic acid—Diarrhoea—Methotrexate—esophageal cancer	0.000113	0.00129	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—esophageal cancer	0.000113	0.0125	CrCbGaD
Mefenamic acid—Dizziness—Methotrexate—esophageal cancer	0.00011	0.00124	CcSEcCtD
Mefenamic acid—Vomiting—Methotrexate—esophageal cancer	0.000105	0.00119	CcSEcCtD
Mefenamic acid—Rash—Methotrexate—esophageal cancer	0.000105	0.00118	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—esophageal cancer	0.000104	0.00118	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—esophageal cancer	0.000104	0.00118	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—esophageal cancer	0.000101	0.0112	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS2—esophageal cancer	9.89e-05	0.0109	CrCbGaD
Mefenamic acid—Nausea—Methotrexate—esophageal cancer	9.85e-05	0.00112	CcSEcCtD
Mefenamic acid—PTGS1—epithelium—esophageal cancer	9.6e-05	0.0386	CbGeAlD
Mefenamic acid—Salicylic acid—ABCB1—esophageal cancer	9.59e-05	0.0106	CrCbGaD
Mefenamic acid—PTGS1—smooth muscle tissue—esophageal cancer	9.25e-05	0.0372	CbGeAlD
Mefenamic acid—PTGS2—epithelium—esophageal cancer	9.17e-05	0.0369	CbGeAlD
Mefenamic acid—PTGS2—bronchus—esophageal cancer	9.03e-05	0.0363	CbGeAlD
Mefenamic acid—Ketoprofen—PTGS2—esophageal cancer	8.95e-05	0.00989	CrCbGaD
Mefenamic acid—PTGS2—smooth muscle tissue—esophageal cancer	8.84e-05	0.0356	CbGeAlD
Mefenamic acid—Diclofenac—ABCB1—esophageal cancer	8.59e-05	0.0095	CrCbGaD
Mefenamic acid—PTGS1—trachea—esophageal cancer	8.48e-05	0.0341	CbGeAlD
Mefenamic acid—PTGS2—trachea—esophageal cancer	8.11e-05	0.0326	CbGeAlD
Mefenamic acid—CYP2C9—digestive system—esophageal cancer	8e-05	0.0322	CbGeAlD
Mefenamic acid—PTGS1—digestive system—esophageal cancer	7.3e-05	0.0294	CbGeAlD
Mefenamic acid—PTGS2—digestive system—esophageal cancer	6.98e-05	0.0281	CbGeAlD
Mefenamic acid—PTGS1—lung—esophageal cancer	6.1e-05	0.0245	CbGeAlD
Mefenamic acid—PTGS2—lung—esophageal cancer	5.83e-05	0.0235	CbGeAlD
Mefenamic acid—PTGS2—Disease—WIF1—esophageal cancer	4.22e-05	0.000355	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—DOCK2—esophageal cancer	4.22e-05	0.000355	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOS3—esophageal cancer	4.19e-05	0.000352	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	4.18e-05	0.000351	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.18e-05	0.000351	CbGpPWpGaD
Mefenamic acid—PTGS1—lymph node—esophageal cancer	4.17e-05	0.0168	CbGeAlD
Mefenamic acid—PTGS2—Metabolism—CA1—esophageal cancer	4.16e-05	0.000349	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC10A2—esophageal cancer	4.16e-05	0.000349	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—HMOX1—esophageal cancer	4.11e-05	0.000345	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.1e-05	0.000345	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.03e-05	0.000339	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HIF1A—esophageal cancer	4.01e-05	0.000337	CbGpPWpGaD
Mefenamic acid—PTGS2—lymph node—esophageal cancer	3.99e-05	0.016	CbGeAlD
Mefenamic acid—CYP2C8—Metabolism—BLVRB—esophageal cancer	3.98e-05	0.000334	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC52A3—esophageal cancer	3.98e-05	0.000334	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ABCB1—esophageal cancer	3.94e-05	0.000332	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH2—esophageal cancer	3.93e-05	0.00033	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CREBBP—esophageal cancer	3.92e-05	0.000329	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—ERBB2—esophageal cancer	3.92e-05	0.000329	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ADH1B—esophageal cancer	3.9e-05	0.000328	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CSNK1A1—esophageal cancer	3.9e-05	0.000327	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HIF1A—esophageal cancer	3.85e-05	0.000324	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KDR—esophageal cancer	3.84e-05	0.000322	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTGS2—esophageal cancer	3.83e-05	0.000322	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CA2—esophageal cancer	3.8e-05	0.00032	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TYMP—esophageal cancer	3.73e-05	0.000314	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.72e-05	0.000312	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.64e-05	0.000306	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—EP300—esophageal cancer	3.64e-05	0.000306	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP26A1—esophageal cancer	3.63e-05	0.000305	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.62e-05	0.000305	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOTCH1—esophageal cancer	3.61e-05	0.000304	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.56e-05	0.000299	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALOX15—esophageal cancer	3.54e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ADH7—esophageal cancer	3.53e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PLCE1—esophageal cancer	3.53e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	3.51e-05	0.000295	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—NOS3—esophageal cancer	3.51e-05	0.000295	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.51e-05	0.000295	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS2—esophageal cancer	3.51e-05	0.000295	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.49e-05	0.000294	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFBR2—esophageal cancer	3.48e-05	0.000293	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOTCH1—esophageal cancer	3.47e-05	0.000292	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC10A2—esophageal cancer	3.38e-05	0.000284	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA1—esophageal cancer	3.38e-05	0.000284	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTO1—esophageal cancer	3.37e-05	0.000284	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TPI1—esophageal cancer	3.37e-05	0.000284	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1A—esophageal cancer	3.35e-05	0.000281	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.34e-05	0.00028	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SMAD4—esophageal cancer	3.3e-05	0.000277	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CREBBP—esophageal cancer	3.28e-05	0.000275	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ELMO1—esophageal cancer	3.27e-05	0.000275	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BLVRB—esophageal cancer	3.24e-05	0.000272	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC52A3—esophageal cancer	3.24e-05	0.000272	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALDOB—esophageal cancer	3.24e-05	0.000272	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—esophageal cancer	3.21e-05	0.00027	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TPI1—esophageal cancer	3.2e-05	0.000269	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GSTO1—esophageal cancer	3.2e-05	0.000269	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EP300—esophageal cancer	3.19e-05	0.000268	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CREBBP—esophageal cancer	3.15e-05	0.000265	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GAPDH—esophageal cancer	3.11e-05	0.000262	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ADH1B—esophageal cancer	3.1e-05	0.000261	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA2—esophageal cancer	3.09e-05	0.00026	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CRABP1—esophageal cancer	3.09e-05	0.000259	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ALDOB—esophageal cancer	3.07e-05	0.000258	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.02e-05	0.000254	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.98e-05	0.000251	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMP—esophageal cancer	2.96e-05	0.000249	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIST1H2BM—esophageal cancer	2.95e-05	0.000248	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GAPDH—esophageal cancer	2.95e-05	0.000248	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GNG7—esophageal cancer	2.94e-05	0.000247	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOS3—esophageal cancer	2.93e-05	0.000247	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.91e-05	0.000244	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.89e-05	0.000243	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP26A1—esophageal cancer	2.88e-05	0.000242	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ADH7—esophageal cancer	2.88e-05	0.000242	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.88e-05	0.000242	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.84e-05	0.000239	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.84e-05	0.000239	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS3—esophageal cancer	2.82e-05	0.000237	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALOX15—esophageal cancer	2.81e-05	0.000236	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—esophageal cancer	2.78e-05	0.000233	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA1—esophageal cancer	2.75e-05	0.000231	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.75e-05	0.000231	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALDH2—esophageal cancer	2.75e-05	0.000231	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB2—esophageal cancer	2.74e-05	0.000231	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—esophageal cancer	2.72e-05	0.000228	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HIF1A—esophageal cancer	2.7e-05	0.000227	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—esophageal cancer	2.69e-05	0.000226	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTO1—esophageal cancer	2.68e-05	0.000225	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TPI1—esophageal cancer	2.68e-05	0.000225	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—EP300—esophageal cancer	2.67e-05	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CREBBP—esophageal cancer	2.64e-05	0.000222	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB2—esophageal cancer	2.64e-05	0.000222	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTT1—esophageal cancer	2.62e-05	0.00022	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—XIAP—esophageal cancer	2.61e-05	0.000219	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP2A6—esophageal cancer	2.59e-05	0.000217	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KDR—esophageal cancer	2.58e-05	0.000217	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—esophageal cancer	2.58e-05	0.000217	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.58e-05	0.000217	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALDOB—esophageal cancer	2.57e-05	0.000216	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ADH1B—esophageal cancer	2.52e-05	0.000212	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA2—esophageal cancer	2.52e-05	0.000212	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GAPDH—esophageal cancer	2.47e-05	0.000208	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.47e-05	0.000207	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.46e-05	0.000207	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ENO1—esophageal cancer	2.45e-05	0.000206	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CRABP1—esophageal cancer	2.45e-05	0.000206	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH1—esophageal cancer	2.43e-05	0.000204	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—B2M—esophageal cancer	2.42e-05	0.000204	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—esophageal cancer	2.42e-05	0.000204	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PSME2—esophageal cancer	2.42e-05	0.000203	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PSME1—esophageal cancer	2.42e-05	0.000203	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMP—esophageal cancer	2.41e-05	0.000203	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.39e-05	0.000201	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—esophageal cancer	2.36e-05	0.000198	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—esophageal cancer	2.36e-05	0.000198	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP26A1—esophageal cancer	2.34e-05	0.000197	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1A—esophageal cancer	2.34e-05	0.000197	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.34e-05	0.000197	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ADH7—esophageal cancer	2.34e-05	0.000197	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GNG7—esophageal cancer	2.33e-05	0.000196	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ENO1—esophageal cancer	2.32e-05	0.000195	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.31e-05	0.000195	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSME1—esophageal cancer	2.29e-05	0.000193	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSME2—esophageal cancer	2.29e-05	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.28e-05	0.000192	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1A—esophageal cancer	2.25e-05	0.000189	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EP300—esophageal cancer	2.23e-05	0.000188	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CREBBP—esophageal cancer	2.2e-05	0.000185	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CALR—esophageal cancer	2.2e-05	0.000185	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALDH2—esophageal cancer	2.18e-05	0.000184	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TPI1—esophageal cancer	2.18e-05	0.000183	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.18e-05	0.000183	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—esophageal cancer	2.16e-05	0.000181	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EP300—esophageal cancer	2.14e-05	0.00018	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FBXW7—esophageal cancer	2.13e-05	0.000179	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.11e-05	0.000177	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.09e-05	0.000176	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.08e-05	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTT1—esophageal cancer	2.08e-05	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2A6—esophageal cancer	2.05e-05	0.000173	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.05e-05	0.000173	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.05e-05	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.01e-05	0.000169	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.99e-05	0.000168	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—esophageal cancer	1.97e-05	0.000166	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—esophageal cancer	1.97e-05	0.000166	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMP—esophageal cancer	1.96e-05	0.000165	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.96e-05	0.000165	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ENO1—esophageal cancer	1.95e-05	0.000164	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTGS1—esophageal cancer	1.95e-05	0.000164	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—esophageal cancer	1.94e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PSME1—esophageal cancer	1.92e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PSME2—esophageal cancer	1.92e-05	0.000161	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.91e-05	0.00016	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—esophageal cancer	1.9e-05	0.00016	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GNG7—esophageal cancer	1.9e-05	0.000159	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—esophageal cancer	1.87e-05	0.000157	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.86e-05	0.000156	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB2—esophageal cancer	1.85e-05	0.000155	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—esophageal cancer	1.83e-05	0.000154	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—EP300—esophageal cancer	1.8e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMOX1—esophageal cancer	1.79e-05	0.00015	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.78e-05	0.000149	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TPI1—esophageal cancer	1.77e-05	0.000149	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.77e-05	0.000149	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.75e-05	0.000148	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFBR2—esophageal cancer	1.72e-05	0.000145	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCB1—esophageal cancer	1.72e-05	0.000144	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.7e-05	0.000143	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.69e-05	0.000142	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.67e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.66e-05	0.00014	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.66e-05	0.000139	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—esophageal cancer	1.65e-05	0.000139	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.64e-05	0.000138	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—esophageal cancer	1.63e-05	0.000137	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SMAD4—esophageal cancer	1.63e-05	0.000137	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.62e-05	0.000136	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—esophageal cancer	1.6e-05	0.000134	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—esophageal cancer	1.59e-05	0.000133	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.58e-05	0.000133	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ENO1—esophageal cancer	1.58e-05	0.000133	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1A—esophageal cancer	1.58e-05	0.000133	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PSME1—esophageal cancer	1.56e-05	0.000131	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PSME2—esophageal cancer	1.56e-05	0.000131	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.56e-05	0.000131	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GNG7—esophageal cancer	1.54e-05	0.00013	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EP300—esophageal cancer	1.5e-05	0.000126	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.45e-05	0.000122	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMOX1—esophageal cancer	1.42e-05	0.000119	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.39e-05	0.000117	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.38e-05	0.000116	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCB1—esophageal cancer	1.36e-05	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.36e-05	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.36e-05	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.35e-05	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.35e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIF1A—esophageal cancer	1.33e-05	0.000112	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—esophageal cancer	1.33e-05	0.000112	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—esophageal cancer	1.31e-05	0.00011	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.3e-05	0.000109	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ENO1—esophageal cancer	1.29e-05	0.000108	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.29e-05	0.000108	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—esophageal cancer	1.28e-05	0.000108	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PSME2—esophageal cancer	1.27e-05	0.000107	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PSME1—esophageal cancer	1.27e-05	0.000107	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS2—esophageal cancer	1.21e-05	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOTCH1—esophageal cancer	1.2e-05	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.16e-05	9.71e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CREBBP—esophageal cancer	1.15e-05	9.65e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.13e-05	9.53e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—esophageal cancer	1.11e-05	9.34e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.11e-05	9.32e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.11e-05	9.32e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.1e-05	9.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CREBBP—esophageal cancer	1.09e-05	9.14e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—esophageal cancer	1.07e-05	9.03e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.03e-05	8.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.03e-05	8.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—esophageal cancer	1.03e-05	8.64e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—esophageal cancer	9.74e-06	8.19e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.4e-06	7.91e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—esophageal cancer	9.4e-06	7.9e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.22e-06	7.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CREBBP—esophageal cancer	9.11e-06	7.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB2—esophageal cancer	9.11e-06	7.66e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCB1—esophageal cancer	9.03e-06	7.59e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.38e-06	7.05e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—esophageal cancer	8.16e-06	6.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—EP300—esophageal cancer	7.81e-06	6.57e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1A—esophageal cancer	7.79e-06	6.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CREBBP—esophageal cancer	7.41e-06	6.23e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EP300—esophageal cancer	7.41e-06	6.23e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.82e-06	5.74e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—esophageal cancer	6.64e-06	5.58e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—esophageal cancer	6.46e-06	5.43e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—esophageal cancer	6.31e-06	5.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—EP300—esophageal cancer	6.2e-06	5.22e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—esophageal cancer	6.07e-06	5.1e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.03e-06	5.07e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—esophageal cancer	5.78e-06	4.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—esophageal cancer	5.48e-06	4.61e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—esophageal cancer	5.4e-06	4.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—EP300—esophageal cancer	5.05e-06	4.24e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.94e-06	4.15e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—esophageal cancer	4.59e-06	3.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—EP300—esophageal cancer	4.11e-06	3.45e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.73e-06	3.14e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.04e-06	2.55e-05	CbGpPWpGaD
